Empagliflozin Reduces Interleukin-6 Levels in Patients with Heart Failure.

Gotzmann, Michael; Henk, Pauline; Stervbo, Ulrik; Blázquez-Navarro, Arturo; Mügge, Andreas; Babel, Nina; Westhoff, Timm H

Gotzmann, Michael; Henk, Pauline; Stervbo, Ulrik; Blázquez-Navarro, Arturo; Mügge, Andreas; Babel, Nina; Westhoff, Timm H.

Afiliación

Gotzmann M; University Hospital St Josef-Hospital, Cardiology and Rhythmology, Ruhr University Bochum, 44791 Bochum, Germany.
Henk P; University Hospital St Josef-Hospital, Cardiology and Rhythmology, Ruhr University Bochum, 44791 Bochum, Germany.
Stervbo U; University Hospital Marien Hospital Herne, Medical Department 1, Ruhr University Bochum, 44625 Herne, Germany.
Blázquez-Navarro A; University Hospital Marien Hospital Herne, Medical Department 1, Ruhr University Bochum, 44625 Herne, Germany.
Mügge A; University Hospital St Josef-Hospital, Cardiology and Rhythmology, Ruhr University Bochum, 44791 Bochum, Germany.
Babel N; University Hospital Marien Hospital Herne, Medical Department 1, Ruhr University Bochum, 44625 Herne, Germany.
Westhoff TH; University Hospital Marien Hospital Herne, Medical Department 1, Ruhr University Bochum, 44625 Herne, Germany.

J Clin Med ; 12(13)2023 Jul 03.

Article en En | MEDLINE | ID: mdl-37445494

Palabras clave

SGLT-2-inhibitors; empagliflozin; heart failure; interleukin 6

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: J Clin Med Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google